Ou Bei (欧贝)欧贝
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司
主要成分Active Ingredients
- 昂丹司琼ondansetron
药物知识说明
昂丹司琼是一种在国家药监局注册认定的药品。该药品含有昂丹司琼-6ddb88c1等成分。
该药品关联的活性成分包括：昂丹司琼ondansetron。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司。
您可以探索含有相同成分的其他药品：昂丹司琼-6ddb88c1成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
ondansetron is a medicine registered with the national drug regulatory authority. It contains ondansetron as active ingredient(s).
Active ingredients associated with this product: ondansetronondansetron.
Manufacturers recorded for this product: 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司.
Explore other medicines containing the same ingredient: ondansetron products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 欧贝Recorded Chinese name: 欧贝
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 4mg*12片4 mg × 12 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970062
关联实体Relationships
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10970062
Manufacturer
Chinese legal name: 齐鲁制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
4 mg × 12 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H10970062
生产企业
齐鲁制药有限公司(国产)
适应症
止吐药。用于：|①细胞毒性药物化疗和放射治疗引起的恶心呕吐；|②预防和治疗手术后的恶心呕吐。
用法用量
1.用于高度催吐的化疗药引起的呕吐：化疗前15分钟、化疗后4小时、8小时各静脉推注射恩丹西酮注射液8mg，停止化疗以后每8～12小时口服恩丹西酮片8mg（2片），连用5天。 |2、对催吐程度不太强的化疗药引起的呕吐：化疗前15分钟静脉注射恩丹西酮注射液8mg，以后每8～12小时口服恩丹西酮片8mg（2片），连用5天。 3、对于放射治疗引起的呕吐：首剂须于放疗前1～2小时口服片剂8mg（2片），以后每8小时口服8mg（2片），疗程视放疗的疗程而定。|4、对于预防手术后的恶心呕吐：在麻醉前1小时口服片剂8mg（2片），随后每隔8小时口服片剂8mg（2片）两次
不良反应
可有头痛、腹部不适、便秘、口干、皮疹、偶见支气管哮喘或过敏反应、短暂性无症状转氨酶增加。上述反应轻微，无须特殊处理。个别患者有癫痫发作。并有胸痛、心律不齐、低血压及心动过缓的罕见报告。
禁忌
对本品过敏者，胃肠梗阻者。
注意事项
1．对肾脏损害患者，无需调整剂量、用药次数和用药途径。|2．对肝功能损害患者，肝功能中度或严重损害患者体内廓清本品的能力显著下降，血清半衰期也显著延长，因此，用药剂量每日不应超过8mg。|3．腹部手术后不宜使用本品，以免掩盖回肠或胃扩张症状。
贮藏
遮光，密封，在阴凉干燥处保存。
规格
4mg*12片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.